MedTrace Logo

Sputum Colour Charts to Guide Antibiotic Self-treatment of Acute Exacerbation of COPD (Colour COPD)

NCT04705233 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2954

Last updated 2022-11-10

No results posted yet for this study

Summary

The primary objective of this study is to determine if a sputum colour chart can aid patient self-management of COPD exacerbations, such that use of the chart is non-inferior to usual care with respect to hospital admissions. There are also a range of other secondary objectives as detailed in the secondary outcomes section. An integral pilot phase, economic evaluation and process evaluation are also included.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

OTHER

sputum colour chart

5-point Sputum Colour Chart plus best standard care

Sponsors & Collaborators

  • Salford Royal Foundation Trust

    collaborator UNKNOWN

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Alice Turner · The University of Birmingham and University Hospitals NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-14
Primary Completion
2023-03-04
Completion
2023-12-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04705233 on ClinicalTrials.gov